Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-07-14

AUTHORS

Jill C Rubinstein, Mario Sznol, Anna C Pavlick, Stephan Ariyan, Elaine Cheng, Antonella Bacchiocchi, Harriet M Kluger, Deepak Narayan, Ruth Halaban

ABSTRACT

Activating mutations in BRAF kinase are common in melanomas. Clinical trials with PLX4032, the mutant-BRAF inhibitor, show promising preliminary results in patients selected for the presence of V600E mutation. However, activating V600K mutation is the other most common mutation, yet patients with this variant are currently excluded from the PLX4032 trials. Here we present evidence that a patient bearing the BRAF V600K mutation responded remarkably to PLX4032, suggesting that clinical trials should include all patients with activating BRAF V600E/K mutations. More... »

PAGES

67

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1479-5876-8-67

DOI

http://dx.doi.org/10.1186/1479-5876-8-67

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009398527

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20630094


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amino Acid Substitution", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Base Sequence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "DNA Mutational Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Indoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Melanoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Sequence Data", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Kinase Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Proto-Oncogene Proteins B-raf", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Skin Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sulfonamides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vemurafenib", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pathology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Pathology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rubinstein", 
        "givenName": "Jill C", 
        "id": "sg:person.01142200502.29", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142200502.29"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sznol", 
        "givenName": "Mario", 
        "id": "sg:person.0706626451.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, New York University, 10016, New York City, New York, USA", 
          "id": "http://www.grid.ac/institutes/grid.137628.9", 
          "name": [
            "Department of Medical Oncology, New York University, 10016, New York City, New York, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pavlick", 
        "givenName": "Anna C", 
        "id": "sg:person.01276612250.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276612250.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ariyan", 
        "givenName": "Stephan", 
        "id": "sg:person.014265505777.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014265505777.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cheng", 
        "givenName": "Elaine", 
        "id": "sg:person.01271010511.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271010511.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bacchiocchi", 
        "givenName": "Antonella", 
        "id": "sg:person.01137303451.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137303451.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kluger", 
        "givenName": "Harriet M", 
        "id": "sg:person.01336750727.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336750727.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Narayan", 
        "givenName": "Deepak", 
        "id": "sg:person.01006374045.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006374045.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA", 
          "id": "http://www.grid.ac/institutes/grid.47100.32", 
          "name": [
            "Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Halaban", 
        "givenName": "Ruth", 
        "id": "sg:person.053601122.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2010-07-14", 
    "datePublishedReg": "2010-07-14", 
    "description": "Activating mutations in BRAF kinase are common in melanomas. Clinical trials with PLX4032, the mutant-BRAF inhibitor, show promising preliminary results in patients selected for the presence of V600E mutation. However, activating V600K mutation is the other most common mutation, yet patients with this variant are currently excluded from the PLX4032 trials. Here we present evidence that a patient bearing the BRAF V600K mutation responded remarkably to PLX4032, suggesting that clinical trials should include all patients with activating BRAF V600E/K mutations.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1479-5876-8-67", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2440220", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "keywords": [
      "V600K mutations", 
      "clinical trials", 
      "BRAF V600E/K mutation", 
      "K mutation", 
      "potential therapeutic response", 
      "mutant BRAF inhibitors", 
      "BRAF inhibitor PLX4032", 
      "BRAF V600K mutation", 
      "melanoma patients", 
      "therapeutic response", 
      "BRAF mutations", 
      "patients", 
      "V600E mutation", 
      "inhibitor PLX4032", 
      "BRAF kinase", 
      "PLX4032", 
      "trials", 
      "common mutations", 
      "mutations", 
      "melanoma", 
      "incidence", 
      "inhibitors", 
      "preliminary results", 
      "kinase", 
      "response", 
      "evidence", 
      "variants", 
      "presence", 
      "results"
    ], 
    "name": "Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032", 
    "pagination": "67", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009398527"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1479-5876-8-67"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20630094"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1479-5876-8-67", 
      "https://app.dimensions.ai/details/publication/pub.1009398527"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_522.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1479-5876-8-67"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-67'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-67'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-67'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1479-5876-8-67'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      20 PREDICATES      67 URIs      59 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1479-5876-8-67 schema:about N00cd6940586842a0bbd300dc3da18f80
2 N302666096ef7403299fe93c32dedf4e7
3 N356456ea20614fae816908cd3effbdc1
4 N53b8f45bfd1b4a79ac9cafcaf1cb82d4
5 N5ecb2b84898a4ad9b8019f7eda92e61f
6 N697adba131294b92a86a94a8ade32105
7 N7180d121a0804092901b295959f1cc08
8 N7999ca47caee4d0982eb392fb88e90dc
9 N817477d3e88e48698e21b2e5735d8dde
10 N89bdae3897a748c5a1edad623d8131d5
11 Ncf210d4ad28e45e38759bc884338e64c
12 Nd697b334a28b4cd799ecd24c842ab136
13 Ndfcddf3ddaea4e75b7ce00e441445d1e
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author N8d8f44d7662d4d63b1b6de29162a60f2
17 schema:datePublished 2010-07-14
18 schema:datePublishedReg 2010-07-14
19 schema:description Activating mutations in BRAF kinase are common in melanomas. Clinical trials with PLX4032, the mutant-BRAF inhibitor, show promising preliminary results in patients selected for the presence of V600E mutation. However, activating V600K mutation is the other most common mutation, yet patients with this variant are currently excluded from the PLX4032 trials. Here we present evidence that a patient bearing the BRAF V600K mutation responded remarkably to PLX4032, suggesting that clinical trials should include all patients with activating BRAF V600E/K mutations.
20 schema:genre article
21 schema:isAccessibleForFree true
22 schema:isPartOf N1484847b420341c9a85205a1383e13e5
23 N8522c50e812d406483caa6ccfc685823
24 sg:journal.1032886
25 schema:keywords BRAF V600E/K mutation
26 BRAF V600K mutation
27 BRAF inhibitor PLX4032
28 BRAF kinase
29 BRAF mutations
30 K mutation
31 PLX4032
32 V600E mutation
33 V600K mutations
34 clinical trials
35 common mutations
36 evidence
37 incidence
38 inhibitor PLX4032
39 inhibitors
40 kinase
41 melanoma
42 melanoma patients
43 mutant BRAF inhibitors
44 mutations
45 patients
46 potential therapeutic response
47 preliminary results
48 presence
49 response
50 results
51 therapeutic response
52 trials
53 variants
54 schema:name Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
55 schema:pagination 67
56 schema:productId N04e05f6a4a2b4526823858da64883043
57 N16e6042fd52f4b1a91b9c1db3b91a0a4
58 Nd05d034a61b945e28b7b25c1a46ccacd
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009398527
60 https://doi.org/10.1186/1479-5876-8-67
61 schema:sdDatePublished 2022-10-01T06:36
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher Na0945e36a867412aa6fcc0bee732e520
64 schema:url https://doi.org/10.1186/1479-5876-8-67
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N00cd6940586842a0bbd300dc3da18f80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Sulfonamides
70 rdf:type schema:DefinedTerm
71 N04e05f6a4a2b4526823858da64883043 schema:name pubmed_id
72 schema:value 20630094
73 rdf:type schema:PropertyValue
74 N0a3953d362074a74a0e6dd4e5238ef44 rdf:first sg:person.014265505777.28
75 rdf:rest Nefece9def00e4463986e405bfe2fa926
76 N1484847b420341c9a85205a1383e13e5 schema:issueNumber 1
77 rdf:type schema:PublicationIssue
78 N16e6042fd52f4b1a91b9c1db3b91a0a4 schema:name dimensions_id
79 schema:value pub.1009398527
80 rdf:type schema:PropertyValue
81 N302666096ef7403299fe93c32dedf4e7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Protein Kinase Inhibitors
83 rdf:type schema:DefinedTerm
84 N356456ea20614fae816908cd3effbdc1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Mutation
86 rdf:type schema:DefinedTerm
87 N4288519a2a9646fabd70b9ceb3651d78 rdf:first sg:person.01276612250.59
88 rdf:rest N0a3953d362074a74a0e6dd4e5238ef44
89 N53b8f45bfd1b4a79ac9cafcaf1cb82d4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Molecular Sequence Data
91 rdf:type schema:DefinedTerm
92 N5ecb2b84898a4ad9b8019f7eda92e61f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Vemurafenib
94 rdf:type schema:DefinedTerm
95 N65658af3ed414657bb12970b73385b54 rdf:first sg:person.0706626451.72
96 rdf:rest N4288519a2a9646fabd70b9ceb3651d78
97 N697adba131294b92a86a94a8ade32105 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Amino Acid Substitution
99 rdf:type schema:DefinedTerm
100 N7180d121a0804092901b295959f1cc08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Proto-Oncogene Proteins B-raf
102 rdf:type schema:DefinedTerm
103 N738d18988dcb46e0aebcc8e396e54934 rdf:first sg:person.01006374045.51
104 rdf:rest N8e9495892d874df39d8e2a6c74f73f2c
105 N7999ca47caee4d0982eb392fb88e90dc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Melanoma
107 rdf:type schema:DefinedTerm
108 N817477d3e88e48698e21b2e5735d8dde schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Skin Neoplasms
110 rdf:type schema:DefinedTerm
111 N8522c50e812d406483caa6ccfc685823 schema:volumeNumber 8
112 rdf:type schema:PublicationVolume
113 N89bdae3897a748c5a1edad623d8131d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Humans
115 rdf:type schema:DefinedTerm
116 N8d8f44d7662d4d63b1b6de29162a60f2 rdf:first sg:person.01142200502.29
117 rdf:rest N65658af3ed414657bb12970b73385b54
118 N8e9495892d874df39d8e2a6c74f73f2c rdf:first sg:person.053601122.01
119 rdf:rest rdf:nil
120 Na0945e36a867412aa6fcc0bee732e520 schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 Nbc350eb1650847e496d98e138d74d87a rdf:first sg:person.01137303451.71
123 rdf:rest Nbfc89bfa1b2f4be4b2225ed70ba3c471
124 Nbfc89bfa1b2f4be4b2225ed70ba3c471 rdf:first sg:person.01336750727.45
125 rdf:rest N738d18988dcb46e0aebcc8e396e54934
126 Ncf210d4ad28e45e38759bc884338e64c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Indoles
128 rdf:type schema:DefinedTerm
129 Nd05d034a61b945e28b7b25c1a46ccacd schema:name doi
130 schema:value 10.1186/1479-5876-8-67
131 rdf:type schema:PropertyValue
132 Nd697b334a28b4cd799ecd24c842ab136 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name DNA Mutational Analysis
134 rdf:type schema:DefinedTerm
135 Ndfcddf3ddaea4e75b7ce00e441445d1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Base Sequence
137 rdf:type schema:DefinedTerm
138 Nefece9def00e4463986e405bfe2fa926 rdf:first sg:person.01271010511.94
139 rdf:rest Nbc350eb1650847e496d98e138d74d87a
140 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
141 schema:name Medical and Health Sciences
142 rdf:type schema:DefinedTerm
143 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
144 schema:name Oncology and Carcinogenesis
145 rdf:type schema:DefinedTerm
146 sg:grant.2440220 http://pending.schema.org/fundedItem sg:pub.10.1186/1479-5876-8-67
147 rdf:type schema:MonetaryGrant
148 sg:journal.1032886 schema:issn 1479-5876
149 schema:name Journal of Translational Medicine
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01006374045.51 schema:affiliation grid-institutes:grid.47100.32
153 schema:familyName Narayan
154 schema:givenName Deepak
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01006374045.51
156 rdf:type schema:Person
157 sg:person.01137303451.71 schema:affiliation grid-institutes:grid.47100.32
158 schema:familyName Bacchiocchi
159 schema:givenName Antonella
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137303451.71
161 rdf:type schema:Person
162 sg:person.01142200502.29 schema:affiliation grid-institutes:grid.47100.32
163 schema:familyName Rubinstein
164 schema:givenName Jill C
165 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142200502.29
166 rdf:type schema:Person
167 sg:person.01271010511.94 schema:affiliation grid-institutes:grid.47100.32
168 schema:familyName Cheng
169 schema:givenName Elaine
170 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271010511.94
171 rdf:type schema:Person
172 sg:person.01276612250.59 schema:affiliation grid-institutes:grid.137628.9
173 schema:familyName Pavlick
174 schema:givenName Anna C
175 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01276612250.59
176 rdf:type schema:Person
177 sg:person.01336750727.45 schema:affiliation grid-institutes:grid.47100.32
178 schema:familyName Kluger
179 schema:givenName Harriet M
180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01336750727.45
181 rdf:type schema:Person
182 sg:person.014265505777.28 schema:affiliation grid-institutes:grid.47100.32
183 schema:familyName Ariyan
184 schema:givenName Stephan
185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014265505777.28
186 rdf:type schema:Person
187 sg:person.053601122.01 schema:affiliation grid-institutes:grid.47100.32
188 schema:familyName Halaban
189 schema:givenName Ruth
190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.053601122.01
191 rdf:type schema:Person
192 sg:person.0706626451.72 schema:affiliation grid-institutes:grid.47100.32
193 schema:familyName Sznol
194 schema:givenName Mario
195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706626451.72
196 rdf:type schema:Person
197 grid-institutes:grid.137628.9 schema:alternateName Department of Medical Oncology, New York University, 10016, New York City, New York, USA
198 schema:name Department of Medical Oncology, New York University, 10016, New York City, New York, USA
199 rdf:type schema:Organization
200 grid-institutes:grid.47100.32 schema:alternateName Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA
201 Department of Pathology, Yale University School of Medicine, 06520, New Haven, CT, USA
202 Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA
203 Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA
204 schema:name Department of Dermatology, Yale University School of Medicine, 06520, New Haven, CT, USA
205 Department of Pathology, Yale University School of Medicine, 06520, New Haven, CT, USA
206 Plastic and Reconstructive Surgery, Yale University School of Medicine, 06520, New Haven, CT, USA
207 Section of Medical Oncology, Yale University School of Medicine, 06520, New Haven, CT, USA
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...